Tumor-Infiltrating Lymphocytes in the Treatment of Solid Tumors

This digital series highlights the mechanistic rationale behind use of tumor-infiltrating lymphocytes in solid tumors, including NSCLC, and addresses the possible challenges and benefits of this treatment approach.